2022
DOI: 10.1016/j.heliyon.2022.e10608
|View full text |Cite
|
Sign up to set email alerts
|

Cisplatin for cancer therapy and overcoming chemoresistance

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
34
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 57 publications
(34 citation statements)
references
References 206 publications
0
34
0
Order By: Relevance
“…Therefore, it is reasonable to speculate that PEI-Pt NCs can exhibit autofluorescence and then play a certain role in the localization of osteosarcoma cells. Third, oxidized platinum (corrosive platinum ions) easily binds to DNA under physiological conditions, causing DNA damage to kill cells, which is the most basic and common anticancer mechanism of platinum drugs. , Therefore, it is reasonable to speculate that PEI-Pt NCs can also exert the traditional platinum drug cell-killing mechanism to exert an anticancer effect in osteosarcoma. The above three points are reasonable conjectures based on previous studies, so this study conducted a series of experimental studies to confirm these expected properties of PEI-Pt NCs.…”
Section: Discussionmentioning
confidence: 99%
“…Therefore, it is reasonable to speculate that PEI-Pt NCs can exhibit autofluorescence and then play a certain role in the localization of osteosarcoma cells. Third, oxidized platinum (corrosive platinum ions) easily binds to DNA under physiological conditions, causing DNA damage to kill cells, which is the most basic and common anticancer mechanism of platinum drugs. , Therefore, it is reasonable to speculate that PEI-Pt NCs can also exert the traditional platinum drug cell-killing mechanism to exert an anticancer effect in osteosarcoma. The above three points are reasonable conjectures based on previous studies, so this study conducted a series of experimental studies to confirm these expected properties of PEI-Pt NCs.…”
Section: Discussionmentioning
confidence: 99%
“…Based on a meta-analysis using ten studies (sample size = 1317), Atashi et al reported 33% cisplatinresistance [27]. Since cisplatin is the first-line systemic treatment for HNC, it then becomes important to overcome cisplatinresistance to improve prognosis [28].…”
Section: Head and Neck Cancersmentioning
confidence: 99%
“…Tumouroid culture model systems have been further developed using different methods, such as microcarriers [34], air-liquid interface (ALI) method [35,36], Microfluidic device, Organoid-On-A-Chip models [28,34], and organoids with bioreactors [34,37]. These methods are currently in a development stage, with a significant focus on the extracellular environment including vascular, neuronal, and immune system input.…”
Section: Future Outlookmentioning
confidence: 99%
“…Cisplatin ( cis -dichlorodiammineplatinum (II)) is an antineoplasic agent widely used in adults and children ( Ranasinghe et al, 2022 ). Upon entering the cell, it binds to DNA, creating platinum covalent adducts which damage DNA, triggering DNA-repair response, oxidative stress and subsequent apoptosis ( Riddell and Lippard, 2018 ; Gentilin et al, 2019 ).…”
Section: Cisplatin Ototoxicity In Zebrafishmentioning
confidence: 99%